尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Gianakakos Anastasios, 董事. Insider active across 1 company, notably LianBio. Cumulatively, 2 filings have been logged. History available since 29 December 2021. The latest transaction was filed on 15 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Anastasios Gianakakos is a Director at LianBio. As a board member, he participates in overseeing the company's operations and making strategic decisions. Anastasios brings significant expertise in the biopharmaceutical sector, allowing him to contribute to the growth and profitability of LianBio. His commitment to corporate governance ensures strong and responsible leadership.